Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center — Indianapolis, Indiana

Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Metastatic Cancer, Advanced Cancer, Relapsed Hodgkin Lymphoma.

Sponsors: Indiana University, Rita Assi, Richard Zellars.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center?

Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center conducted?

Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center has 4 clinical trials on record, with 3 currently active. Their work covers Metastatic Cancer, Advanced Cancer, Relapsed Hodgkin Lymphoma.

Is Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center accredited by Crixeo Health?

Yes — Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.